BeStock  
Stocks › Biotechnology › CRMD

CorMedix CRMD

US equityMarket cap rank #3658Biotechnology
$7.28 +$0.00 (0.00%)
Pre-market · Oct 8, 8:20 am ET · After hours $7.30 +0.28%
Open$7.27
Prev close$7.28
Day range$7.18 – $7.31
Volume833.1K
Market cap$567.43M
P/E (TTM)3.3
Dividend yield–

CRMD Stock News

Headlines matching CorMedix or the CRMD ticker, most recent first.

  • Analysts Are Bullish on Top Healthcare Stocks: Parabilis Medicines, Inc. (PBLS), Cormedix (CRMD) PositiveTipRanks · 14 Aug 2026 · Direct mention
  • Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $15Market news · 14 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13Market news · 14 Aug 2026 · Direct mention
  • RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $14 PositiveMarket news · 14 Aug 2026 · Direct mention
  • RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $13 NegativeMarket news · 7 Jul 2026 · Direct mention
  • Truist Financial Maintains CorMedix(CRMD.US) With Buy RatingMarket news · 15 May 2026 · Direct mention
  • A Quick Look at Today's Ratings for CorMedix(CRMD.US), With a Forecast Between $13 to $15Market news · 15 May 2026 · Direct mention
  • RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13Market news · 9 Apr 2026 · Direct mention
  • Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $14Market news · 15 Apr 2026 · Direct mention
  • Leerink Partners Maintains CorMedix(CRMD.US) With Buy Rating, Announces Target Price $13Market news · 7 Mar 2026 · Direct mention
  • Needham Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $14 NegativeMarket news · 6 Mar 2026 · Direct mention
  • Analysts' Top Healthcare Picks: Cormedix (CRMD), CG Oncology, Inc. (CGON)TipRanks · 4 Feb 2026 · Direct mention
  • Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $16Market news · 9 Jan 2026 · Direct mention
  • Needham Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $15 NegativeMarket news · 9 Jan 2026 · Direct mention
  • Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating, Announces Target Price $16Market news · 9 Jan 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on CRMD.

Leave a comment

Scroll to Top